Synthetic Bt Gene Codon Optimization for Plant Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The expression of Bacillus thuringiensis (B.t.) genes in plants is problematic, resulting in low levels of stable mRNA and protein production, leading to inadequate insecticidal efficacy, due to factors such as high A+T content, potential polyadenylation signals, and ATTTA sequences affecting mRNA stability and processing.

Innovation Solution

Modification of the B.t. gene sequences by removing ATTTA sequences and potential polyadenylation signals through site-directed mutagenesis, and optimizing codon usage to enhance mRNA stability and translation efficiency, while maintaining the amino acid sequence and avoiding restriction sites, to create synthetic genes with improved expression levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If B.t. genes with high A+T content are introduced into plants, then the genes can be successfully transformed and expressed, but the mRNA stability decreases and protein production levels remain low

Engineering Contradiction:
Improvegene transformation successVSAvoidmRNA stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent removes destabilizing sequences (ATTTA motifs and polyadenylation signals) from the B.t. gene coding region to eliminate their harmful effects on mRNA stability while preserving the essential insecticidal function of the toxin protein

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent modifies the nucleotide sequence parameters of the B.t. gene by replacing A+T rich codons with G+C containing codons that encode the same amino acids, thereby changing the mRNA sequence composition to improve stability without altering the protein product

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If the native B.t. gene sequence is used, then the amino acid sequence is preserved, but the translation efficiency and protein expression levels are low

Engineering Contradiction:
Improveamino acid sequence accuracyVSAvoidprotein expression level
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent optimizes codon usage by replacing rare B.t. codons with plant-preferred codons, thereby improving translation efficiency and protein expression levels while maintaining the exact same amino acid sequence through synonymous codon substitutions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a synthetic copy of the B.t. gene with optimized nucleotide sequence that is transcriptionally and translationally optimized for plant cells, while the amino acid sequence remains identical to the native toxin

Inventive Principle:
Principle #26Copying

3Stability of the object's composition

If ATTTA sequences are present in the B.t. gene, then the gene maintains its native structure, but mRNA degradation is accelerated and expression levels decrease

Engineering Contradiction:
Improvegene structure integrityVSAvoidmRNA half-life
Core Design Contradiction:
Stability of the object's compositionVSDuration of action of stationary object

Solution Approach 1:

The patent specifically removes ATTTA destabilizing sequences from the B.t. gene coding region by site-directed mutagenesis, eliminating their capacity to accelerate mRNA degradation while preserving the functional integrity of the toxin protein

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent identifies and exploits the harmful effect of ATTTA sequences on mRNA stability by deliberately removing them, thereby converting a potentially detrimental feature into a benefit through targeted sequence modification

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

4Manufacturing precision

If potential polyadenylation signals are present in the B.t. gene, then the gene sequence remains authentic, but premature transcription termination occurs and full-length mRNA is reduced

Engineering Contradiction:
Improvegene sequence authenticityVSAvoidfull-length mRNA amount
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent removes potential polyadenylation signals (such as AATAAA and variants) from the B.t. gene coding sequence through site-directed mutagenesis, preventing premature transcription termination and ensuring production of full-length mRNA

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces point mutations at specific nucleotide positions within polyadenylation signal motifs, thereby interfering with their function as transcription termination signals while maintaining the reading frame and amino acid sequence

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS7741118B1Synthetic plant genes and method for preparation
Publication Date: 2010.06.22 MONSANTO TECHNOLOGY LLC
  • US7741118B1 patent drawing
  • US7741118B1 patent drawing
  • US7741118B1 patent drawing

AI summary

A method for modifying structural gene sequences to enhance the expression of the protein product is disclosed. Also disclosed are novel structural genes which encode insecticidal proteins of B.t.k. HD-1, B.t.k. HD-73, B.t. tenebrionis, B.t. entomocidus, 2 protein of B.t.k. HD-1, and the coat protein of potato leaf roll virus.